KeyCorp Issues Pessimistic Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its target price decreased by equities researchers at KeyCorp from $420.00 to $370.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s price objective points to a potential upside of 18.90% from the company’s current price.

A number of other equities research analysts also recently weighed in on the company. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Morgan Stanley reduced their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday. Finally, TD Cowen cut their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $311.19 on Tuesday. HCA Healthcare has a 1-year low of $276.50 and a 1-year high of $417.14. The company has a market capitalization of $78.82 billion, a price-to-earnings ratio of 13.97, a P/E/G ratio of 1.21 and a beta of 1.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock’s fifty day simple moving average is $323.68 and its 200-day simple moving average is $354.18.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HCA Healthcare

Several institutional investors have recently added to or reduced their stakes in the stock. Terra Nova Asset Management LLC boosted its position in HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after acquiring an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its stake in shares of HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after buying an additional 29 shares in the last quarter. Waldron Private Wealth LLC increased its stake in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management lifted its position in shares of HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares during the last quarter. Finally, UMB Bank n.a. boosted its position in HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after purchasing an additional 30 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.